DIOSYNTH

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 Jun 2025 filing date already counts against anyone who files later.

Record

Serial number

99232608

Mark type

Stylized text

Filed

13 Jun 2025

Published for opposition

07 Apr 2026

Attorney of record

Suzanne M. Hengl

Goods and services

• Class 001 — Chemicals: Chemical preparations and substances, namely, chemical additives for use in the manufacturing of pharmaceutical products, namely, chemical preparations and substances for manufacturing pharmaceutical products for veterinary applications; chemical additives for manufacturing medicines, namely, pharmaceuticals; Chemicals, namely, chemical additives for use in the manufacturing of cosmetics, skin cleansers and medicines, namely, pharmaceuticals; chemical preservatives for use in the production of a wide variety for chemicals for pharmaceutical preparations; Biochemicals, namely, polypeptides, recombinant proteins, organic peptide substrates and monoclonal antibodies for scientific purposes, namely, genetic pharmacology
• Class 005 — Pharmaceuticals: Medicines and pharmaceutical products, namely medicines and pharmaceutical products for veterinary use, namely, medicines and pharmaceutical preparations for the treatment and prevention of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital disorders and, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory disease, respiratory and infectious diseases, immunological, bacterial, viral and fungal disorders, mental illness, depression, psychosis, bone and mineral diseases, infertility, menopausal complaints, hormone deficiencies, and sleep disorders; Medical pharmaceutical preparations, namely, preparations for lowering cholesterol, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations, contraceptives, muscle relaxants, muscle relaxant antagonists; biotechnological preparations, namely, pharmaceutical preparations for medical use, namely use in gene therapy; Biochemicals, namely, biochemical reagent preparations for medical use, namely, for use in gene therapy; genetic material for medical use, namely, genetically engineered tissue for transplant purposes for genetic cell therapy
• Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals
• Class 042 — Scientific and technological services: Services of biotechnical, chemical and pharmacological laboratories, namely, scientific and technological research, namely, production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations; scientific and technological research, namely, production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations, and scientific research consultation related thereto; scientific research, namely, conducting early evaluations in the field of new pharmaceutical medicines; development of products for others, namely, pharmaceutical preparations, medicines and medicaments; technological services, namely, technological consultation and research as related to medical products in the field of new product development in the pharmaceutical and health care industries; scientific analysis and research, namely, evaluation of pharmaceutical products; research and development in the field of pharmaceutical medicines; scientific research and development in the field of medicines; product development for others, namely, preparation of pharmaceutical test products; advisory services relating to the field of scientific research, development and analyses of medicines; development of new technologies for others in the biotechnology sector; providing information about scientific research in the field of biochemistry and biotechnology; scientific research for the medical sector in the field of cancerous diseases

Owner

• FUJIFILM Corporation, Tokyo, JP

Prosecution history

• 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 13 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 28 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 28 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 28 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 13 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 13 Nov 2025 — NON-FINAL ACTION E-MAILED
• 13 Nov 2025 — NON-FINAL ACTION WRITTEN
• 03 Nov 2025 — ASSIGNED TO EXAMINER
• 21 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 13 Jun 2025 — APPLICATION FILING RECEIPT MAILED
• 13 Jun 2025 — NEW APPLICATION ENTERED